Relevance of biomarkers in disease progression in multiple sclerosis

被引：1
|
作者：
Kanodia, A. K. [1 ]
机构：
[1] Ninewells Hosp, Dept Radiol, Dundee, Scotland
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2017年 / 24卷 / 01期
关键词：
NATALIZUMAB-TREATED PATIENTS; BRAIN ATROPHY;
D O I：
10.1111/ene.13170
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：7 / 8
页数：2
相关论文
共 50 条
  • [1] CSF Biomarkers of Disease Progression in Patients with Multiple Sclerosis
    Zanker, Shayna
    Harris, Violaine
    Sadiq, Saud
    [J]. NEUROLOGY, 2017, 88
  • [2] Serum Biomarkers of Clinical and Radiographic Disease Progression in Multiple Sclerosis
    Qureshi, Ferhan
    Oechtering, Johanna
    Keshavan, Anisha
    McCurdy, Shannon
    Maceski, Aleksandra Maleska
    Willemse, Eline
    Meier, Stephanie
    Ghoreyshi, Ati
    Jalaleddini, Kian
    Leyden, Kelly
    Leppert, David
    Melie-Garcia, Lester
    Granziera, Cristina
    Schadelin, Sabine
    Benkert, Pascal
    Kuhle, Jens
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 302 - 303
  • [3] Extending lipid biomarkers of disease progression in people with multiple sclerosis
    Mckechnie, Charlie
    Gafson, Arie
    Savva, Constantinos
    Matthews, Paul
    [J]. NEUROLOGY, 2017, 88
  • [4] Eye Movement Biomarkers for Early Detection of Multiple Sclerosis Disease Progression
    Giacomini, P.
    Bastien, N.
    Chernock, M.
    Voss, P.
    Blanchette, F.
    Arsemeau, F.
    Hussein, S.
    Ramos, R.
    de Villers-Sidani, E.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 27 - 28
  • [5] Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis
    Cross, Anne H.
    Gelfand, Jeffrey M.
    Thebault, Simon
    Bennett, Jeffrey L.
    von Buedingen, H. Christian
    Cameron, Briana
    Carruthers, Robert
    Edwards, Keith
    Fallis, Robert
    Gerstein, Rachel
    Giacomini, Paul S.
    Greenberg, Benjamin
    Hafler, David A.
    Ionete, Carolina
    Kaunzner, Ulrike W.
    Kodama, Lay
    Lock, Christopher
    Longbrake, Erin E.
    Musch, Bruno
    Pardo, Gabriel
    Piehl, Fredrik
    Weber, Martin S.
    Yuen, Steven
    Ziemssen, Tjalf
    Bose, Gauruv
    Freedman, Mark S.
    Anania, Veronica G.
    Ramesh, Akshaya
    Winger, Ryan C.
    Jia, Xiaoming
    Herman, Ann
    Harp, Christopher
    Bar-Or, Amit
    [J]. JAMA NEUROLOGY, 2024, 81 (04) : 373 - 383
  • [6] Using circulatory biomarkers to predict disease progression in multiple sclerosis (MS)
    Haham, N.
    Brill, L.
    Rappoport, N.
    Zveik, O.
    Rechtman, A.
    Vaknin-Dembinsky, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 531 - 531
  • [7] Proteomics discovery of novel CSF biomarkers for disease progression in multiple sclerosis
    Teunissen, C. E.
    Koel-Simmelink, M. J. A.
    Piersma, S.
    Pham, T.
    Killestein, J.
    Vrenken, H.
    Berven, F.
    Jimenez, C. R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 504 - 504
  • [8] Identifying biomarkers for monitoring progression of multiple sclerosis
    Chase, Carol Ann
    Raphael, Itay
    Forsthuber, Thomas
    [J]. JOURNAL OF IMMUNOLOGY, 2016, 196
  • [9] MRI biomarkers of disease progression and conversion to secondary-progressive multiple sclerosis
    Tavazzi, Eleonora
    Zivadinov, Robert
    Dwyer, Michael G.
    Jakimovski, Dejan
    Singhal, Tarun
    Weinstock-Guttman, Bianca
    Bergsland, Niels
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2020, 20 (08) : 821 - 834
  • [10] Serum Lactate and Uric Acid as Biomarkers for Disease Activity and Progression in Multiple Sclerosis
    Hassan, Amr
    Mehaney, Dina
    [J]. EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2015, 52 (02): : 127 - 131
12345